Alzheimer Disease Clinical Trial
Official title:
Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic
Verified date | July 2022 |
Source | Yeditepe University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our aim has been determined to investigate the effect of physical exercise alone and in combination with cognitive exercise, on cognitive, physical function and quality of life in individuals with Alzheimer's Disease during the Covid-19 pandemic period.
Status | Completed |
Enrollment | 60 |
Est. completion date | December 25, 2021 |
Est. primary completion date | July 23, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - = 65 years and older - Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist, - MOCA = 13 - Clinical Dementia Rating Scale < 2 - Having sufficient wireless support or telephone connection where the person lives - Who gave consent to participate in the study - No history of any neurological or orthopedic injury that could prevent participation in the study and affect functional mobility. Exclusion Criteria: - Geriatric Depression Scale score > 11 - Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.) - Clinically significant aphasia (must be able to understand the therapist's commands) - Significant visual or sensory impairment - MoCA < 13 - Having a severe musculoskeletal disorder - Having paralysis - Impaired balance - The presence of severe lung and heart disease |
Country | Name | City | State |
---|---|---|---|
Turkey | Yeditepe University | Istanbul | Eyalet/Yerleske |
Lead Sponsor | Collaborator |
---|---|
Yeditepe University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Alzheimer's Disease Related Quality of Life Scale | This scale evaluates health-related quality of life in individuals with AD. The scale includes 40 questions in total and examines 5 quality of life domains (A-Social Interaction, B-Self Awareness, C-Affect and Mood, D- Enjoying Activities, E-Interaction with the Environment). | 24 weeks | |
Primary | Montreal Cognitive Assessment Scale | MOCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment. | 24 weeks | |
Primary | Berg Balance Scale | Berg Balance Scale measures static and dynamic balance in elderly individuals. | 24 weeks | |
Primary | Time up and Go Test | TUG test evaluates fall risk, mobility and physical performance in the elderly | 24 weeks | |
Primary | Sit to Stand Test | Sit-to-stand test will be performed on an armless chair with a height of 46 cm to determine the physical fitness level of elderly individuals | 24 weeks | |
Primary | Arm Curl Test | The Arm Curl test is one of the subtests of the Senior fitness test and it is performed to evaluate upper extremity muscle strength | 24 weeks | |
Secondary | Katz Activities of Daily Living Scale | Katz ADLs consist of six questions that include information about bathing, dressing, toilet, movement, excretion, and feeding activities. | 24 weeks | |
Secondary | Lawton Instrumental Activities of Daily Living Scale | Lawton IADL scale consists of 8 items and a single subscale. In addition, it consists of eight questions about using the phone, preparing meals, shopping, doing daily household chores, washing clothes, getting on the transportation vehicle, taking medicines and money management | 24 weeks | |
Secondary | Geriatric Depression Scale (Short Form) | The GDS Short Form (GDS-15) is a 15-item scale that is used for the diagnosis of depression in elderly individuals | 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |